Worldwide experts release clinical recommendations for management of ATM cancer risk 

Researchers established decades ago that ataxia-telangiectasia mutated (ATM) heterozygotes are at an increased risk for cancer, there remains a need to provide clear guidance for clinicians.

Study identifies that higher West African ancestry may contribute to worse breast cancer outcomes 

The study found that West African genetic ancestry was associated with shorter disease-free survival, particularly for women with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.

Curbing late-stage breast cancer diagnosis: Innovative mobile diagnostic kit aims to improve early detection in Uganda

An international team of experts, including the Uganda Cancer Institute, is developing a groundbreaking mobile breast cancer diagnostic kit to enhance early detection in Uganda, where 70% of cases are diagnosed at an advanced stage.

Protocol improves follow-up for women at high risk for breast cancer 

Before the protocol, every patient underwent a Breast Cancer Risk Assessment Tool evaluation, yet there was no established protocol for sharing the results.

Powerful Collaboration

Journal Watch